Skip to content

Comparison of Effectiveness of Two Different Electrotherapy Agents on Central Sensitization

Effects of Transcutaneous Electrical Nerve Stimulation (TENS) and Interferential Currents (IFC) on Central Sensitization in Patients With Knee Osteoarthritis: Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04153825
Enrollment
80
Registered
2019-11-06
Start date
2019-02-01
Completion date
2020-02-01
Last updated
2019-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Keywords

Physical therapy modalities, Osteoarthritis knee, Central nervous system sensitization, Pain, Electric Stimulation Therapy

Brief summary

The aim of this study is to compare the efficacy of transcutaneous electrical nerve stimulation (TENS), interferential currents (IFCs) and sham devices in improving central sensitization (CS) findings, including pressure pain thresholds, pain catastrophizing, depression, and kinesiophobia in patients with knee osteoarthritis (OA).

Detailed description

Knee OA, which is the most frequently encountered type of OA is a leading cause of disability and chronic pain. CS is as important as nociceptive component in the pathogenesis of OA-related pain. Therefore, the necessary interventions for CS should be also considered when deciding the treatment protocol.TENS and IFC have been safely and commonly employed in the conservative treatment of knee OA. However, there are limited and inconsistent data concerning the impact of these modalities on CS component of pain.Therefore, the aim of this study is to investigate whether these agents are effective on CS and they are superior to each other.

Interventions

DEVICETranscutaneous Electrical Nerve Stimulation

Electrodes are placed around painful regions determined by the patient as patients are in the sitting position with the knees extended. The device is set at pulse duration of 50 to 80 μs; pulse frequency of 50 to 100 Hz; low-intensity (paraesthesia, not painful). The patient wears TENS for a 20-minute duration for each knee.

Electrodes are placed diagonally around the painful areas defined by the patient, with the patient in the sitting position with the knees extended. The device is set at carrier frequency 4000 Hz, amplitude modulated frequency (AMF) 100 Hz, scanning frequency 50 Hz, scanning mode 1: 1 s. The patient wears ICF for a 20-minute duration for each knee.

OTHERHydrocollator hot-pack

The hot-pack (at a surface temperature of almost 42 °C) is administered on knees while patients are in sitting position with the knees extended. Every session includes 20 minutes of hot-pack for each knee.

Electrodes are placed around painful regions determined by the patient as patients are in the sitting position with the knees extended.TENS unit in place but not turned on.The patient wears TENS for a 20-minute duration for each knee.

Electrodes are placed diagonally around the painful areas defined by the patient, with the patient in the sitting position with the knees extended. IFC unit in place but not turned on.The patient wears ICF for a 20-minute duration for each knee.

Sponsors

Turkish League Against Rheumatism
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

40 to 75 years of age, Having bilateral knee OA radiologically with a Kellgren-Lawrence grade of 2 or 3. Reporting knee pain of more than 3 on the visual analog scale (VAS) over the last 6 months Being unfamiliar with TENS and IFC use \-

Exclusion criteria

1. Having the history of any contraindication for electrotherapy (pacemakers, epilepsy, dermatological conditions, abnormal sensation in the knees, pregnancy), 2. Having a knee surgery or intra-articular corticosteroid or hyaluronic acid injection within 6 months. 3. Taking any drugs acting on the nervous system such as anticonvulsants, antidepressants, myorelaxants, or opioid drugs in the study period. 4. Having fibromyalgia, inflammatory rheumatologic, severe psychological disorders -

Design outcomes

Primary

MeasureTime frameDescription
Pressure-pain thresholdsChange from baseline pressure-pain thresholds at 2 weeks and at 12 weeksPressure pain thresholds is measured on the knee (M. Vastus Medialis) and on the upper part of the homolateral arm (lateral part of M. Deltoideus, 10 cm below acromion) using a pressure algometer. The pressure is raised at a rate of almost 1 kg/s, until the patient first notifies that the pressure sensation changes to a pain sensation.
Tampa Scale of KinesiophobiaChange from baseline kinesiophobia scores at 2 weeks and at 12 weeksTampa Scale contains 17 parts that measure anxiety and fear related to movement. The total score ranges between 17-68 points. Higher scores represent higher grades of kinesiophobia.
Beck Depression Inventory (BDI)Change from baseline BDI scores at 2 weeks and at 12 weeks.Beck Depression Inventory is a 21-item questionnaire that examines the characteristic symptoms of depression.
Pain catastrophizing scale (PCS)Change from baseline PCS scores at 2 weeks and at 12 weeks.PCS consists of 13 items in three subscales (rumination, helplessness, and magnification). Higher final score indicates more catastrophic thinking related to pain.

Secondary

MeasureTime frameDescription
ComorbidityBaselineself reported
Visual analogue scale (VAS)Change from baseline, at 2 weeks and at 12 weeksVAS ranging levels from 0 (no pain) to 10 (maximal pain).
AgeBaselineyears
Timed Up and Go Test (TUG)Change from baseline, at 2 weeks and at 12 weeksTimed up and go test is used to assess mobility which recorded the time of rising from a back-rest chair, walking at a normal pace 3 meters, turning, walking back to the chair, and sitting recumbently. In one minute durations, each participant will perform the test three times and this time will be recorded in seconds.
Five Times Sit to Stand TestChange from baseline, at 2 weeks and at 12 weeksThe participant is asked to sit-to-stand action from a standard chair five times as quickly as possible, and the time taken to complete is recorded.
Western Ontario and McMaster University (WOMAC) Index.Change from baseline, at 2 weeks and at 12 weeksThere are three subscales with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a total WOMAC score. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
GenderBaselinefemale/male
HeightBaselinecentimeter (cm)
WeightBaselinekilogram (kg)

Countries

Turkey (Türkiye)

Contacts

Primary ContactŞahide E Almaz, MD
edartuc@gmail.com+905534488730
Backup ContactHatice Bodur, Professor
haticebodur@gmail.com+905054848496

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026